ijms-logo

Journal Browser

Journal Browser

Advances in Aging and Alzheimer’s Disease Research: From Molecular Mechanisms to Therapeutics—2nd Edition

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 34

Special Issue Editor

Special Issue Information

Dear Colleagues,

Aging is an inevitable process common to all humans and a major risk factor for several age-related diseases, including neurodegenerative diseases. During human aging, neurodegenerative diseases and their associated cognitive deficits, which affect human health and life, are prevalent. Alzheimer's disease (AD) is one of the most common neurodegenerative brain diseases, a main symptom of which is the functional decline and disruption of the blood–brain barrier, which is characterized by the accumulation of amyloid-β plaques, neural disassembly, synaptic dysfunction, and cellular damage to neurons, as well as other brain cells in the brain parenchyma. These effects can lead to memory impairment, behavioral changes, the loss of cognitive function, and dementia.

For this Special Issue of the International Journal of Molecular Sciences, we aim to gather insights into the pathogenesis of Alzheimer's disease, barrier dysfunction, neuronal transmission, brain changes associated with aging, oxidative stress, mitochondrial dysfunction, and the identification of amyloid, tau, and p-tau, as well as other biomarkers.

Dr. Lilach Soreq
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aging
  • Alzheimer’s disease
  • bioinformatics
  • RNA-seq
  • Parkinson’s disease

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop